UltraSight Series B2 (2026)
UltraSight raised $24 million in a Series B2 round, announced on 2026-09-23. The round was led by Alive HealthTech Growth Fund.
- Company
- UltraSight
- Round type
- Series B2
- Date
- 2026-09-23
- Amount
- $24M
- Industry
- cardiac imaging, healthcare AI, medical devices
- Location
- Cambridge, MA
Summary
UltraSight raised $24 million in Series B2 financing on 2026-09-23, led by Alive HealthTech Growth Fund, with Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures and existing investors Mayo Clinic Ventures, NYU and Iron Nation.
Investors
Lead
Participating
- Deep Insight participant
- Star51 Capital participant
- Connecticut Innovations participant
- eHealth Ventures participant
- Mayo Clinic Ventures participant
- NYU participant
- Iron Nation participant
Sources
Last verified:
- https://ultrasight.com/ultrasight-raises-24-million-to-scale-its-ai-guided-cardiac-workflow-platform-across-u-s-health-systems/
Type: company announcement. Accessed 2026-10-07.
UltraSight release dated Cambridge, Mass., 2026-09-23. Announces $24 million Series B2 led by Alive HealthTech Growth Fund with Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures and existing investors Mayo Clinic Ventures, NYU and Iron Nation. - https://www.finsmes.com/2026/09/ultrasight-raises-24m-in-series-b2-funding.html
Type: reputable publication. Accessed 2026-10-07.
FinSMEs article dated 2026-09-23. Confirms the $24 million Series B2, lead and participants. It gives the location as Boston, MA, while the company release is datelined Cambridge, Mass. This page uses Cambridge.